Profile
Joe Rayne is currently Head-Investor Relations at Nuvation Bio, Inc. Formerly, Mr. Rayne was Head-Investor Relations at Inotek Pharmaceuticals Corp.
and Vice President at Argot Partners LLC from 2017 to 2021.
Joe Rayne active positions
| Companies | Position | Start |
|---|---|---|
| NUVATION BIO INC. | Investor Relations Contact | - |
Former positions of Joe Rayne
| Companies | Position | End |
|---|---|---|
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Corporate Officer/Principal | 31/07/2021 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Investor Relations Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Commercial Services |
Nuvation Bio, Inc.
Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
- Stock Market
- Insiders
- Joe Rayne
















